Pen or syringe? new study tests easier way to take risankizumab
NCT ID NCT06946524
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tested how well risankizumab enters the body when given by a prefilled pen compared to a traditional syringe. It involved 59 healthy adults and measured drug levels, side effects, and immune response. The goal was to see if the pen works as well as the syringe, which could make future injections easier for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Acpru /Id# 275116
Grayslake, Illinois, 60030, United States
-
Altasciences Clinical Los Angeles /ID# 276446
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.